...
首页> 外文期刊>Eye Science >In Vivo Observations and Electron Microscopy of Treatment of Experimental HSV Keratitis with Anti-HSV Monoclonal Antibodies
【24h】

In Vivo Observations and Electron Microscopy of Treatment of Experimental HSV Keratitis with Anti-HSV Monoclonal Antibodies

机译:抗HSV单克隆抗体治疗实验性HSV角膜炎的体内观察和电子显微镜观察

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To study the antiviral activity of monoclonal antibodies (McAb) in vivo and identify their effects on experimental herpetic keratitis. Methods: Topical use of anti-HSV monoclonal glycoprotein antibodies was carried out on acute herpetic keratitis of rabbits infected by HSV-1 SM_(44). The application of the eye drops in each group was five times per day for 14 days by double-blind method. In vivo observation and electron microscopy were performed during the whole procedure. The anti-HSV McAb's solution was mixed up of five monoclonal antibodies with high neutrilization titers and/or high ADCC activity. Results: Compared with placebo-treated eyes, anti-HSV McAb treatment made statistically significant reduction of herpetic corneal epithelial lesion on rabbits from day 3 to day 14 postinnoculation (P < 0.01). Punctate and short dendritic lesion were the main patterns. The area of involvement was also limited. Electron microscopic analysis showed ultrastructural changes of herpetic corneal infection. The clumping of nuclear chromatin, swollon nuclei, reduction of microfla-ment, rounding of epithelial cells were apparent in placebo-treated eyes. The advanced lesion of the viral infection was karyolysis, karyoklasis and disruption of cells in both scanning and transmission electron micrographes. The management of the McAb-treated eyes showed that the pathological involvements as mentioned above reduced remarkablely. Conclusion: Topical application of anti-HSV monoclonal antibodies produced marked antiviral effects in inhibiting the developement of experimental herpetic keratitis in rabbits and in protecting the susceptible corneal cells. As a new biological product, the anti-HSV monoclonal antibodies may provide a new approach to the treatment of HSV keratits.
机译:目的:研究单克隆抗体(McAb)的体内抗病毒活性,并确定其对实验性疱疹性角膜炎的作用。方法:对HSV-1 SM_(44)感染的兔急性疱疹性角膜炎进行局部使用抗HSV单克隆糖蛋白抗体。采用双盲法,每组每天滴眼液5次,共14天。在整个过程中进行体内观察和电子显微镜检查。抗HSV单克隆抗体溶液混合了五种具有高中和效价和/或高ADCC活性的单克隆抗体。结果:与安慰剂治疗的眼睛相比,抗HSV McAb治疗在接种后第3天至第14天使兔子的疱疹性角膜上皮病变明显减少(P <0.01)。主要形态为点状和树突状病变。参与领域也很有限。电子显微镜分析显示疱疹性角膜感染的超微结构变化。在安慰剂治疗的眼睛中,核染色质团块,肿胀的核,微细丝减少,上皮细胞变圆是明显的。病毒感染的晚期病变在扫描和透射电子显微镜下均为核解,核分裂症和细胞破坏。经McAb治疗的眼睛的处理显示,上述病理病变明显减少。结论:局部应用抗HSV单克隆抗体在抑制家兔实验性疱疹性角膜炎的发展以及保护易感角膜细胞方面具有明显的抗病毒作用。作为一种新的生物产品,抗HSV单克隆抗体可能为HSV角蛋白的治疗提供一种新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号